Status:
UNKNOWN
Positive Predictive Value (PPV) of Pseudomonas Aeruginosa
Lead Sponsor:
MolecuLight Inc.
Collaborating Sponsors:
Scarborough Rouge Hospital
Conditions:
Wound
Chronic Leg Ulcer
Eligibility:
All Genders
18+ years
Brief Summary
This is a non-randomized, single-blind post market clinical follow-up study for which 65 patients will be imaged at Rouge Valley Centenary Hospital (Scarborough and Rouge Hospital) who present with a ...
Eligibility Criteria
Inclusion
- Male or female patients presenting with a chronic wound (wound duration \> 4 weeks) e.g. diabetic foot ulcer, venous leg ulcer, pressure ulcer, or other acceptable aetiology
- 18 years or older
Exclusion
- Treatment with an investigational drug within 1 month before study enrolment
- Inability to consent to medical photography (i.e. inability to understand consent process)
- Any contra-indication to routine wound care and/or monitoring
- Prior participation of the patient in this study (for the same wound or a different wound).
Key Trial Info
Start Date :
August 4 2017
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
July 30 2020
Estimated Enrollment :
65 Patients enrolled
Trial Details
Trial ID
NCT03290690
Start Date
August 4 2017
End Date
July 30 2020
Last Update
March 6 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Scarborough and Rouge Hospital
Scarborough Village, Ontario, Canada, M1E 4B9